Horsham, PA, United States of America

Chengzao Sun

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 7.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: The Innovations of Chengzao Sun

Introduction

Chengzao Sun is a notable inventor based in Horsham, PA (US). He has made significant contributions to the field of biomedical research, particularly in the development of peptide inhibitors for treating inflammatory diseases. With a total of two patents to his name, his work has the potential to impact many lives.

Latest Patents

Chengzao Sun's latest patents include innovative peptide inhibitors of the interleukin-23 receptor. These inventions provide novel methods and compositions for treating or preventing a variety of diseases and disorders, including inflammatory bowel diseases. His research focuses on the therapeutic applications of these peptide inhibitors, showcasing his commitment to advancing medical science.

Career Highlights

Throughout his career, Chengzao Sun has worked with prominent companies in the biotechnology sector. Notable among these are Janssen Biotech, Inc. and Protagonist Therapeutics, Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Chengzao Sun has collaborated with several talented individuals, including Brian Troy Frederick and Sandeep Somani. These partnerships have enriched his research and fostered innovation in the development of new therapeutic approaches.

Conclusion

Chengzao Sun's contributions to the field of biomedical research through his patents and collaborations highlight his role as an influential inventor. His work in developing peptide inhibitors for inflammatory diseases demonstrates the potential for innovation to improve healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…